Myc Translocation Is an Adverse Factor Redefining High-Risk Multiple Myeloma

Xianghong Jin(Sir Run Run Shaw Hospital), Junling Zhuang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuangjiao Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yang Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Miao Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Hui Li(Shanghai Stomatological Hospital), Fujing Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianhua Du(Academy of Medical Sciences), Daobin Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College)
Blood
November 15, 2022
10.1182/blood-2022-169332
Cited by 0

Related Papers

Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells
|Cell stem cell|2019|179
Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis
|Journal of Autoimmunity|2019|173
IL-27 triggers IL-10 production in Th17 cells via a c-Maf/RORγt/Blimp-1 signal to promote the progression of endometriosis
|Cell Death and Disease|2017|137
Preconditioning of umbilical cord‐derived mesenchymal stem cells by rapamycin increases cell migration and ameliorates liver ischaemia/reperfusion injury in mice via the CXCR4/CXCL12 axis
|Cell Proliferation|2018|88
Mild-Temperature Photothermal Effect Triggers Simultaneous Nitric Oxide- and Deferoxamine-Releasing Mesoporous Polydopamine-Based Nanoplatform for Robust Antibacterial, Anti-inflammation, and Wound-Healing Activity
|Chemistry of Materials|2022|50